XcelCyte A/S: Financial statements 2022
CVR: 41466162
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
XcelCyte A/S (CVR 41466162) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -77,818 and a net result of DKK -157,336 compared with DKK -2,058,059 the year before. Equity in the 2022 report amounted to DKK 36,614. The solvency ratio was 13%.
- Gross Profit
- DKK -77,818
- Profit/Loss
- DKK -157,336
- Equity
- DKK 36,614
- Total Assets
- DKK 281,780
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -78 t. | -157 t. | 37 t. | 0 |
| 2021 | - | -2.2 mio. | -2.1 mio. | 194 t. | 1 |
Official annual report
Keep an eye on XcelCyte A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
XcelCyte A/S has published its annual report for 2021. Gross profit came to DKK -2,214,502, and the net result was DKK -2,058,059.
As of May 16, 2022, A/S PSE 17 NR. 1056 has stepped down as auditor of XcelCyte A/S.
About XcelCyte A/S
XcelCyte A/S was a Danish company of the type Aktieselskab based in Aarhus C, founded in 2020. The company has been dissolved on 17 July 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2021). In 2024, the company reported a gross profit of DKK -16,526 and a net result of DKK -19,254 compared with DKK -36,278 the year before. Equity in the 2024 report amounted to DKK -18,918.